Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 137

    1.

    Protease polymorphisms in HIV-1 subtype CRF01_AE represent selection by antiretroviral therapy and host immune pressure.

    Manosuthi W, Butler DM, Pérez-Santiago J, Poon AF, Pillai SK, Mehta SR, Pacold ME, Richman DD, Pond SK, Smith DM.

    AIDS. . [Epub ahead of print]PMID: 20009919 [PubMed - as supplied by publisher]

    2.

    Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute coronary syndrome patients: the Canadian global registry of acute coronary events (GRACE) experience.

    Banihashemi B, Goodman SG, Yan RT, Welsh RC, Mehta SR, Montalescot G, Kornder JM, Wong GC, Gyenes G, Steg PG, Yan AT; Global Registry of Acute Coronary Events (GRACE/GRACE(2)) Investigators.

    Am Heart J. 2009 Dec;158(6):917-24.PMID: 19958857 [PubMed - in process]Related articles

    3.

    Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction.

    Goyal A, Mehta SR, Díaz R, Gerstein HC, Afzal R, Xavier D, Liu L, Pais P, Yusuf S.

    Circulation. 2009 Dec 15;120(24):2429-37. Epub .PMID: 19948980 [PubMed - in process]Related articles

    4.

    Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the OASIS-5 trial.

    Anderson JA, Hirsh J, Yusuf S, Johnston M, Afzal R, Mehta SR, Fox KA, Budaj A, Eikelboom JW.

    J Thromb Haemost. 2009 Nov 26. [Epub ahead of print]PMID: 19943881 [PubMed - as supplied by publisher]Related articles

    5.

    The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis.

    Berger JS, Bhatt DL, Cannon CP, Chen Z, Jiang L, Jones JB, Mehta SR, Sabatine MS, Steinhubl SR, Topol EJ, Berger PB.

    J Am Coll Cardiol. 2009 Nov 17;54(21):1935-45. Review.PMID: 19909874 [PubMed - indexed for MEDLINE]Related articles

    6.

    Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial.

    Jolly SS, Faxon DP, Fox KA, Afzal R, Boden WE, Widimsky P, Steg PG, Valentin V, Budaj A, Granger CB, Joyner CD, Chrolavicius S, Yusuf S, Mehta SR.

    J Am Coll Cardiol. 2009 Jul 28;54(5):468-76.PMID: 19628124 [PubMed - indexed for MEDLINE]Related articles

    7.

    Routine early angioplasty after fibrinolysis for acute myocardial infarction.

    Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, Morrison LJ, Langer A, Dzavik V, Mehta SR, Lazzam C, Schwartz B, Casanova A, Goodman SG; TRANSFER-AMI Trial Investigators.

    N Engl J Med. 2009 Jun 25;360(26):2705-18.PMID: 19553646 [PubMed - indexed for MEDLINE]Related articles

    8.

    Early versus delayed invasive intervention in acute coronary syndromes.

    Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, Afzal R, Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht HJ, Zhu J, Col J, Natarajan MK, Horsman C, Fox KA, Yusuf S; TIMACS Investigators.

    N Engl J Med. 2009 May 21;360(21):2165-75.PMID: 19458363 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial.

    Sculpher MJ, Lozano-Ortega G, Sambrook J, Palmer S, Ormanidhi O, Bakhai A, Flather M, Steg PG, Mehta SR, Weintraub W.

    Am Heart J. 2009 May;157(5):845-52.PMID: 19376310 [PubMed - indexed for MEDLINE]Related articles

    10.

    Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction.

    Goyal A, Mehta SR, Gerstein HC, Díaz R, Afzal R, Xavier D, Zhu J, Pais P, Lisheng L, Kazmi KA, Zubaid M, Piegas LS, Widimsky P, Budaj A, Avezum A, Yusuf S.

    Am Heart J. 2009 Apr;157(4):763-70. Epub 2009 Feb 20.PMID: 19332208 [PubMed - indexed for MEDLINE]Related articles

    11.

    Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6.

    Karthikeyan G, Mehta SR, Eikelboom JW.

    Expert Rev Cardiovasc Ther. 2009 Mar;7(3):241-9.PMID: 19296760 [PubMed - indexed for MEDLINE]Related articles

    12.

    Aspirin for prevention and treatment of cardiovascular disease.

    Mehta SR.

    Ann Intern Med. 2009 Mar 17;150(6):414-6. No abstract available. PMID: 19293075 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk.

    Joyner CD, Peters RJ, Afzal R, Chrolavicius S, Mehta SR, Fox KA, Granger CB, Franzosi MG, Flather M, Budaj A, Bassand JP, Yusuf S.

    Am Heart J. 2009 Mar;157(3):502-8.PMID: 19249421 [PubMed - indexed for MEDLINE]Related articles

    14.

    Differences in tuberculin reactivity as determined in a veterans administration employee health screening program.

    Mehta SR, MacGruder C, Looney D, Johns S, Smith DM.

    Clin Vaccine Immunol. 2009 Apr;16(4):541-3. Epub 2009 Feb 18.PMID: 19225075 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trials.

    Swahn E, Alfredsson J, Afzal R, Budaj A, Chrolavicius S, Fox K, Jolly S, Mehta SR, de Winter R, Yusuf S.

    Eur Heart J. 2009 Feb 7. [Epub ahead of print]PMID: 19202154 [PubMed - as supplied by publisher]Related articles

    16.

    Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials.

    Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR.

    Am Heart J. 2009 Jan;157(1):132-40. Epub 2008 Nov 1. Review.PMID: 19081409 [PubMed - indexed for MEDLINE]Related articles

    17.

    Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy.

    Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Fox KA, Granger CB, Jolly S, Rupprecht HJ, Widimsky P, Yusuf S; CURRENT-OASIS 7 Steering Committee.

    Am Heart J. 2008 Dec;156(6):1080-1088.e1. Epub 2008 Nov 1.PMID: 19033002 [PubMed - indexed for MEDLINE]Related articles

    18.

    Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.

    Mehta SR, Boden WE, Eikelboom JW, Flather M, Steg PG, Avezum A, Afzal R, Piegas LS, Faxon DP, Widimsky P, Budaj A, Chrolavicius S, Rupprecht HJ, Jolly S, Granger CB, Fox KA, Bassand JP, Yusuf S; OASIS 5 and 6 Investigators.

    Circulation. 2008 Nov 11;118(20):2038-46. Epub 2008 Oct 27. Erratum in: Circulation. 2008 Dec 16;118(25):e842. PMID: 18955665 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Real-time in vivo green fluorescent protein imaging of a murine leishmaniasis model as a new tool for Leishmania vaccine and drug discovery.

    Mehta SR, Huang R, Yang M, Zhang XQ, Kolli B, Chang KP, Hoffman RM, Goto Y, Badaro R, Schooley RT.

    Clin Vaccine Immunol. 2008 Dec;15(12):1764-70. Epub 2008 Oct 22.PMID: 18945882 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study.

    Jolly SS, Pogue J, Haladyn K, Peters RJ, Fox KA, Avezum A, Gersh BJ, Rupprecht HJ, Yusuf S, Mehta SR.

    Eur Heart J. 2009 Apr;30(8):900-7. Epub 2008 Sep 26.PMID: 18819961 [PubMed - indexed for MEDLINE]Related articles

    21.

    Incidental findings in healthy control research subjects using whole-body MRI.

    Morin SH, Cobbold JF, Lim AK, Eliahoo J, Thomas EL, Mehta SR, Durighel G, Fitzpatrick J, Bell JD, Taylor-Robinson SD.

    Eur J Radiol. 2009 Dec;72(3):529-33. Epub 2008 Sep 24.PMID: 18818038 [PubMed - in process]Related articles

    22.

    Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes.

    Budaj A, Eikelboom JW, Mehta SR, Afzal R, Chrolavicius S, Bassand JP, Fox KA, Wallentin L, Peters RJ, Granger CB, Joyner CD, Yusuf S; OASIS 5 Investigators.

    Eur Heart J. 2009 Mar;30(6):655-61. Epub 2008 Aug 18.PMID: 18713759 [PubMed - indexed for MEDLINE]Related articles

    23.

    Non-invasive means of measuring hepatic fat content.

    Mehta SR, Thomas EL, Bell JD, Johnston DG, Taylor-Robinson SD.

    World J Gastroenterol. 2008 Jun 14;14(22):3476-83.PMID: 18567074 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use.

    Sabatine MS, Hamdalla HN, Mehta SR, Fox KA, Topol EJ, Steinhubl SR, Cannon CP.

    Am Heart J. 2008 May;155(5):910-7. Epub 2008 Feb 21.PMID: 18440341 [PubMed - indexed for MEDLINE]Related articles

    25.

    The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial.

    Peters RJ, Joyner C, Bassand JP, Afzal R, Chrolavicius S, Mehta SR, Oldgren J, Wallentin L, Budaj A, Fox KA, Yusuf S; OASIS-6 investigators.

    Eur Heart J. 2008 Feb;29(3):324-31.PMID: 18245119 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment.

    Oldgren J, Wallentin L, Afzal R, Bassand JP, Budaj A, Chrolavicius S, Fox KA, Granger CB, Mehta SR, Pais P, Peters RJ, Xavier D, Zhu J, Yusuf S; OASIS-6 Investigators.

    Eur Heart J. 2008 Feb;29(3):315-23. Epub 2007 Dec 15.PMID: 18084015 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.

    Díaz R, Goyal A, Mehta SR, Afzal R, Xavier D, Pais P, Chrolavicius S, Zhu J, Kazmi K, Liu L, Budaj A, Zubaid M, Avezum A, Ruda M, Yusuf S.

    JAMA. 2007 Nov 28;298(20):2399-405.PMID: 18042917 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: a long-term analysis based on the CURE trial.

    Kolm P, Yuan Y, Veledar E, Mehta SR, O'Brien JA, Weintraub WS.

    Can J Cardiol. 2007 Nov;23(13):1037-42.PMID: 17985004 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial.

    Mehta SR, Granger CB, Eikelboom JW, Bassand JP, Wallentin L, Faxon DP, Peters RJ, Budaj A, Afzal R, Chrolavicius S, Fox KA, Yusuf S.

    J Am Coll Cardiol. 2007 Oct 30;50(18):1742-51. Epub 2007 Oct 15.PMID: 17964037 [PubMed - indexed for MEDLINE]Related articles

    30.

    Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes.

    Fox KA, Bassand JP, Mehta SR, Wallentin L, Theroux P, Piegas LS, Valentin V, Moccetti T, Chrolavicius S, Afzal R, Yusuf S; OASIS 5 Investigators.

    Ann Intern Med. 2007 Sep 4;147(5):304-10.PMID: 17785485 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Views of primary care providers on follow-up care of cancer patients.

    Nissen MJ, Beran MS, Lee MW, Mehta SR, Pine DA, Swenson KK.

    Fam Med. 2007 Jul-Aug;39(7):477-82.PMID: 17602321 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Renal function and outcomes in acute coronary syndrome: impact of clopidogrel.

    Keltai M, Tonelli M, Mann JF, Sitkei E, Lewis BS, Hawken S, Mehta SR, Yusuf S; CURE Trial Investigators.

    Eur J Cardiovasc Prev Rehabil. 2007 Apr;14(2):312-8.PMID: 17446813 [PubMed - indexed for MEDLINE]Related articles

    33.

    Management of malaria: recent trends.

    Mehta SR, Das S.

    J Commun Dis. 2006 Mar;38(2):130-8. Review.PMID: 17370675 [PubMed - indexed for MEDLINE]Related articles

    34.

    Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI).

    Tran H, Mehta SR, Eikelboom JW.

    Vasc Health Risk Manag. 2006;2(4):379-87. Review.PMID: 17323592 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Adverse impact of bleeding on prognosis in patients with acute coronary syndromes.

    Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S.

    Circulation. 2006 Aug 22;114(8):774-82. Epub 2006 Aug 14.PMID: 16908769 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Opportunities to improve outcomes in sickle cell disease.

    Mehta SR, Afenyi-Annan A, Byrns PJ, Lottenberg R.

    Am Fam Physician. 2006 Jul 15;74(2):303-10. Review.PMID: 16883928 [PubMed - indexed for MEDLINE]Related articles

    37.

    Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial.

    Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, Budaj A, Peters RJ, Bassand JP, Wallentin L, Joyner C, Fox KA; OASIS-6 Trial Group.

    JAMA. 2006 Apr 5;295(13):1519-30. Epub 2006 Mar 14.PMID: 16537725 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Comparison of fondaparinux and enoxaparin in acute coronary syndromes.

    Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators, Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, Budaj A, Peters RJ, Bassand JP, Wallentin L, Joyner C, Fox KA.

    N Engl J Med. 2006 Apr 6;354(14):1464-76. Epub 2006 Mar 14.PMID: 16537663 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Aspirin resistance and its implications in clinical practice.

    Eikelboom J, Feldman M, Mehta SR, Michelson AD, Oates JA, Topol E.

    MedGenMed. 2005 Jul 11;7(3):76.PMID: 16369302 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions.

    Natarajan MK, Velianou JL, Turpie AG, Mehta SR, Raco D, Goodhart DM, Afzal R, Ginsberg JS.

    Am Heart J. 2006 Jan;151(1):175.PMID: 16368313 [PubMed - indexed for MEDLINE]Related articles

    41.

    Disseminated Strongyloides stercoralis in AIDS: a report from India.

    Satyanarayana S, Nema S, Kalghatgi AT, Mehta SR, Rai R, Duggal R, Bhardwaj JR.

    Indian J Pathol Microbiol. 2005 Oct;48(4):472-4.PMID: 16366097 [PubMed - indexed for MEDLINE]Related articles

    42.

    Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.

    Eikelboom JW, Quinlan DJ, Mehta SR, Turpie AG, Menown IB, Yusuf S.

    Circulation. 2005 Dec 20;112(25):3855-67. Epub 2005 Dec 12.PMID: 16344381 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.

    Lewis BS, Mehta SR, Fox KA, Halon DA, Zhao F, Peters RJ, Keltai M, Budaj A, Yusuf S; CURE trial investigators.

    Am Heart J. 2005 Dec;150(6):1177-84.PMID: 16338255 [PubMed - indexed for MEDLINE]Related articles

    44.

    Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes.

    MICHELANGELO OASIS 5 Steering Committee, Mehta SR, Yusuf S, Granger CB, Wallentin L, Peters RJ, Bassand JP, Budaj A, Joyner C, Chrolavicius S, Fox KA.

    Am Heart J. 2005 Dec;150(6):1107.PMID: 16338245 [PubMed - indexed for MEDLINE]Related articles

    45.

    Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery.

    Cannon CP, Mehta SR, Aranki SF.

    Ann Thorac Surg. 2005 Aug;80(2):768-79. Review.PMID: 16039260 [PubMed - indexed for MEDLINE]Related articles

    46.

    Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials.

    Mehta SR, Cannon CP, Fox KA, Wallentin L, Boden WE, Spacek R, Widimsky P, McCullough PA, Hunt D, Braunwald E, Yusuf S.

    JAMA. 2005 Jun 15;293(23):2908-17.PMID: 15956636 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial.

    Mehta SR, Steg PG, Granger CB, Bassand JP, Faxon DP, Weitz JI, Afzal R, Rush B, Peters RJ, Natarajan MK, Velianou JL, Goodhart DM, Labinaz M, Tanguay JF, Fox KA, Yusuf S; ASPIRE Investigators.

    Circulation. 2005 Mar 22;111(11):1390-7.PMID: 15781750 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes.

    Mehta SR, Eikelboom JW, Demers C, Maggioni AP, Commerford PJ, Yusuf S.

    Can J Physiol Pharmacol. 2005 Jan;83(1):98-103.PMID: 15759056 [PubMed - indexed for MEDLINE]Related articles

    49.

    Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.

    Mehta SR, Yusuf S, Díaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L; CREATE-ECLA Trial Group Investigators.

    JAMA. 2005 Jan 26;293(4):437-46.PMID: 15671428 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation.

    Yusuf S, Mehta SR, Xie C, Ahmed RJ, Xavier D, Pais P, Zhu J, Liu L; CREATE Trial Group Investigators.

    JAMA. 2005 Jan 26;293(4):427-35.PMID: 15671427 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...